Jeffrey Robert Ajer - 15 Mar 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role: EVP, Chief Commercial Officer
Signature: /s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol: BMRN
Transactions as of: 15 Mar 2022
Net transactions value: -$762,764
Form type: 4
Filing time: 17 Mar 2022, 21:11:22 UTC
Previous filing: 10 Mar 2022
Next filing: 24 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BMRN	Common Stock	Award	$0	+11,940	+18%	$0.000000	77,163	15 Mar 2022	Direct	F1
transaction	BMRN	Common Stock	Tax liability	$658,877	-8,418	-11%	$78.27	68,745	15 Mar 2022	Direct
transaction	BMRN	Common Stock	Tax liability	$103,887	-1,287	-1.9%	$80.72	67,458	16 Mar 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BMRN	Stock Option (Right to buy Common Stock)	Award	$0	+28,670		$0.000000	28,670	15 Mar 2022	Common Stock	28,670	$78.27	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units granted on March 15, 2022. Price not applicable.
F2	Option grant vests 12/48th on March 15, 2023 and 1/48th on the 15th day of each month thereafter.